tiprankstipranks
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market
Holding ELVN?
Track your performance easily

Enliven Therapeutics (ELVN) Technical Analysis

286 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
6Neutral
12Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Enliven Therapeutics’s (ELVN) Moving Averages Convergence Divergence (MACD) indicator is -0.61, suggesting Enliven Therapeutics is a Buy.
Enliven Therapeutics’s (ELVN) 20-Day exponential moving average is 26.45, while Enliven Therapeutics’s (ELVN) share price is $24.54, making it a Sell.
Enliven Therapeutics’s (ELVN) 50-Day exponential moving average is 26.24, while Enliven Therapeutics’s (ELVN) share price is $24.54, making it a Sell.

Enliven Therapeutics (ELVN) Pivot Points

Nov 23, 2024, 08:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
23.74
24.22
24.81
25.29
25.88
26.36
26.95
Fibonacci
24.22
24.63
24.88
25.29
25.70
25.95
26.36
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enliven Therapeutics (ELVN) Moving Averages

Nov 23, 2024, 08:37 AM
Period
Simple
Exponential
MA5
25.29Sell
25.22Sell
MA10
25.64Sell
25.77Sell
MA20
27.03Sell
26.45Sell
MA50
26.53Sell
26.24Sell
MA100
24.85Sell
24.88Sell
MA200
22.12Buy
21.90Buy
Enliven Therapeutics’s (ELVN) 10-Day exponential moving average is 25.77, while Enliven Therapeutics’s (ELVN) share price is $24.54, making it a Sell.
Enliven Therapeutics’s (ELVN) 100-Day exponential moving average is 24.88, while Enliven Therapeutics’s (ELVN) share price is $24.54, making it a Sell.
Enliven Therapeutics’s (ELVN) stock price is $24.54 and Enliven Therapeutics’s (ELVN) 50-day simple moving average is 26.53, creating a Sell signal.
Enliven Therapeutics’s (ELVN) stock price is $24.54 and Enliven Therapeutics’s (ELVN) 100-day simple moving average is 24.85, creating a Sell signal.
Enliven Therapeutics’s (ELVN) stock price is $24.54 and Enliven Therapeutics’s (ELVN) 200-day simple moving average is 22.12, creating a Buy signal.

Enliven Therapeutics (ELVN) Technical Indicators

Nov 23, 2024, 08:37 AM
Name
Value
Implied Action
RSI (14)
36.67
Neutral
STOCH (9,6)
26.35
Neutral
STOCHRSI (14)
23.45
Neutral
MACD (12,26)
-0.61
Buy
ADX (14)
24.44
Neutral
Williams %R
-86.20
Buy
CCI (14)
-97.93
Neutral
ATR (14)
1.40
-
Ultimate Oscillator
45.18
Neutral
ROC
-11.25
Sell
Enliven Therapeutics’s (ELVN) Relative Strength Index (RSI) is 36.67, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Trend Strength Indicator (ADX) is 24.44, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Commodity Channel Index (CCI) is -97.93, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Price Rate of Change (ROC) is -11.25, creating a Sell signal.

FAQ

Is ELVN a Buy, Hold, or Sell?
Based on ELVN’s technical indicators, ELVN is a Sell.
    What is ELVN’s RSI (14)?
    ELVN’s RSI (14) is 36.67, which suggests ELVN is a Neutral.
      What is ELVN’s MACD?
      ELVN’s MACD is -0.61, which suggests ELVN is a Buy.
        What is ELVN’s 5-day moving average?
        ELVN’s 5-day moving average is 25.29, which suggests ELVN is a Sell.
          What is ELVN’s 20-day moving average?
          ELVN 20-day moving average is 27.03, which suggests ELVN is a Sell.
            What is ELVN’s 50-day moving average?
            ELVN’s 50-day moving average is 26.53, which suggests ELVN is a Sell.
              What is ELVN’s 200-day moving average?
              ELVN’s 200-day moving average is 22.12, which suggests ELVN is a Buy.
                What is ELVN’s Williams % R (14)?
                ELVN’s Williams % R (14) is -86.20, which suggests ELVN is a Buy.
                  What is ELVN’s CCI (14)?
                  ELVN’s CCI (14) is -97.93, which suggests ELVN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis